NEW YORK (Reuters Health) – Treatment of depression in low-income minorities with poorly controlled diabetes improved HbA1c and systolic blood pressure, investigators report in the December issue of…
NEW YORK (Reuters Health) – The use of undersized drug-eluting stents for saphenous vein graft lesions may reduce the long-term incidence of emboli and enzyme elevations without increasing…
NEW YORK (Reuters Health) – In children with attention deficit hyperactivity disorder (ADHD), adding divalproex to stimulant therapy can improve refractory aggression, a small study suggests. “Stimulant medications…
NEW YORK (Reuters Health) – Core needle biopsies seem almost as accurate as open biopsy in detecting breast cancer, and less prone to complications, a meta-analysis has found.…
NEW YORK (Reuters Health) – The Prove-it sepsis assay (Mobidiag, Helsinki, Finland) is highly sensitive and specific in identifying bacterial species in blood samples and provides much faster…
NEW YORK (Reuters Health) – Recombinant human erythropoietin (EPO) provides no benefit after acute ischemic stroke, and may even be dangerous, particularly in patients receiving systemic thrombolysis. These…
NEW YORK (Reuters Health) – New research shows that antidiabetes agents are not equal when it comes to cardiovascular risks and mortality. According to a report in the…
NEW YORK (Reuters Health) – In treating patients with metastatic melanoma, thalidomide plus temozolomide is no better than temozolomide or dacarbazine alone, according to a report in the…
Scott Flanders, MD, President of the Society of Hospital Medicine, Associate Professor of Medicine, University of Michigan, discusses what the future holds for pediatric hospitalists, in terms of…
Dr Mark Del Beccaro, MD, Pediatrician in Chief, Chief Medical Information Officer and Vice Chair of Clinical Affairs for the Department of Pediatrics at Seattle Children’s Hospital, Professor…
